Two Related Cases of Primary Complement Deficiency

Immunological Investigations

Volumn 32, Issue 4, 2003, Pages 313-321

  Farhoudi, A ^a   Bazargan, N ^a   Pourpak, Z ^a,b   Mahmoudi, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C1 esterase inhibitor; Hereditary angioedema; Primary C3deficiency; Stanazol

Indexed keywords

ANTIBIOTIC AGENT; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; DANAZOL; STANOZOLOL;

ADULT; ANGIONEUROTIC EDEMA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL MENINGITIS; BLOOD LEVEL; CASE REPORT; COMPLEMENT DEFICIENCY; DYSPNEA; FACE EDEMA; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GLOMERULONEPHRITIS; HUMAN; LARYNX EDEMA; MALE; PRIORITY JOURNAL;

EID: 0242381247     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-120025108     Document Type: Article

References (31)

1. International Union of Immunological Societies. (1999). Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin. Exp. Immunol. 118(Suppl. 1):26.
2. Alper, C. A., Propp, R. P., Klemperer, M. R., Rosen, F. S, (1969). Inherited deficiency of the third component of human complement (C3). J. Clin. Invest. 48(3):553-557.
3. Austen, K. F. (1998). Allergies, anaphylaxis and systemic mastocytosis. In: Braunwald, E., Fauci, A., Kasper, D. L., Hauser, S. L., Lago, D. L., Jameson, J. L., eds. Harrison's Principles of Internal Medicine. New York: Mc Graw Hill, pp. 1917-1919.
4. Ballow, M., Shira, J. E., Harden, L., Yang, S. Y., Day, N. K. (1975). Complete absence of the third component of complement in man. J. Clin. Invest. 56:703-710.
5. Beyer, L. L, Baehner, R. L. (1992). Laboratory evaluation of neutropenia and neutrophil disfunction. In: Rose, N. R., de Macario, E. C., Fahey, J. L., Friedman, H., Penn, G. M., eds. Manual of Clinical Laboratory Immunology. Washigton, DC: American Society of Microbiology, pp. 409-419.
6. Brai, M., Accardo, P., Bellavia, D. (1994). Polymorphism of the complement components in human pathology. Ann. Ital. Med. Interna 9(3):167-172.
7. Ellison, R. T. III, Kohler, P. F., Curd, J. G., Judson, F. N., Reller, L. B. (1983). Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease. N. Engl. J. Med. 308(16):913-916.
8. 3 in the immune response. Immunol. Today 12(9):332-337.
9. Farhoudi, A. H. (1988). Recurrent pneumococcal meningitis associated with C3 deficiency. Presse Med. 17(14):696.
10. 3 deficiency. Acta Med. Iran. 29:33.
11. Feigin, R. D., Dodge, P. R. (1998). Bacterial meningitis beyond the neonatal period. In: Feigin, Cherry, eds. Textbook of Pediatric Infectious Diseases. Philadelphia: W.B. Saunders, pp. 400-430.
12. Holers, V. M. (2001). Complement deficiencies. In: Rich, R. R., Fleisher, T. A., Shearer, W. T, Kotzin, B. L., Schroeder, H. W. Jr., eds. Clinical Immunology: Principles and Practice. London: Mosby, pp. 36.1-36.10.
13. Johnson, R. B. Jr. (1996). Disorders of the complement system. In: Stiehm, E. R., ed. Immunologic Disorders in Infants and Children. Philadelphia: Saunders, pp. 491 - 495.
14. Johnson, R. B. Jr. (2000). Primary deficiencies of complement components. In: Behrman, R. E., Kliegman, R. M., Jenson, H. B., eds. Nelson Text Book of Pediatrics. Philadelphia: Saunders, pp. 631-633.
15. Klein-Gitelman, M. S., Miller, M. L. (2000). Systemic lupus erythematosus. In: Behrman, R. G., Kliegman, R. M., Jenson, H. B., eds. Nelson Text Book of Pediatrics. Philadelphia: Saunders, pp. 713-717.
16. Levinsky, R. J., Harvey, B. A., Paleja, S. (1978). A rapid objective method for measuring the yeast opsonisation activity of serum. J. Immunol. Methods 24(3-4):251-256.
17. Liszewski, M. K., Atkinson, J. P. (2000). Inherited and acquired disorders of the complement system. www.Uptodate.Com
18. 3) and the hypocomplementemic cutaneous vasculitis syndrome. Am. J. Med. 68(4):549-558.
19. Morgan, B. P., Walport, M. J. (1991). Complement deficiency and disease. Immunol. Today 12(9):301-306.
20. 1, Inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema. Lab. Invest. 65(4):381-388.
21. Palacios, A. S., Medina, F. S., Marrero, A. G. (1998). Chronic angioedema. Three relevant cases. Allergol. Immunopathol. (Madr.) 26(4):195-198.
22. Peleg, D., Harit-Bastan, H., Katz, Y., Peller, S., Schlesinger, M., Schnofeld, S. (1992). Inherited C3 deficiency and meningococcal disease in a teenager. Pediatr. Infect. Dis. J. 11(5):401-404.
23. Prellner, K. (1981). Complement in pneumococcal infections with varying degree of severity. Scand. J. Infect. Dis. 13(4):263-268.
24. Roord, J. J., Van Diemen-Van Steenvoorde, R. A., Schuurman, H. J., Rijkers, G. T., Zegers, B. J., Gmelig Meyling, F. H., Stoop, J. W. (1989). Membranoproliferative glomerulonephritis in a patient with congenital deficiency of the third component of complement: effect of treatment with plasma. Am. J. Kidney. Dis. 13(5):413-417.
25. Ross, S. C., Densen, P. (1984). Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63(5):243-273.
26. Schamber, P. C. (2000). Immunology. In: Siberry, G. K., Iannone, R., eds. The Harriet Lane Handbook. Baltimore: Mosby, pp. 333-345.
27. Soothill, J. F., Harvey, B. A. (1977). A defect of the alternate pathway of complement. Clin. Exp. Immunol. 27(1):30-33.
28. Southwick, F. S., Stossel, T. P. (1986). Phagocytosis. In: Rose, N. R., Friedman, H., Fahey, J. L., eds. Manual of Clinical Laboratory Immunology. Washington, DC: American Society for Microbiology, pp. 326-331.
29. Stray-Pedersen, A., Abrahamsen, T. G., Froland, S. S. (2000). Primary immunodeficiency disease in Norway. J. Clin. Immunol. 20(6):477-485.
30. 1-Esterase inhibitor transfusions in patients with hereditary angioedema. Ann. Allergy, Asthma, & Immun. 80(6):457-461.
31. 1 inhibitor mutations in patients with hereditary angioedema. J. Allergy Clin. Immunol. 105:541-546.